Estimates Revisions Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
01:22:52 2026-08-21 pm EDT
|
5-day change | 1st Jan Change | ||
| 55.93 USD | +1.23% |
|
+6.47% | +26.95% |
| 12:46pm | Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating | MT |
| 10:45am | Scholar Rock withdraws Europe filing for muscle weakness drug, plans resubmission | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- SRRK Stock
- Consensus Scholar Rock Holding Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
